Overview BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Status: Withdrawn Trial end date: 2021-03-22 Target enrollment: Participant gender: Summary BOL-DP-o-05 as an Add-On Treatment for Preservation of Beta-Cell Function in Subjects With Newly-Diagnosed Type 1 Diabetes Mellitus (T1DM) Phase: Phase 1/Phase 2 Details Lead Sponsor: Breath of Life International Pharma Ltd